Activity of antiviral enzyme 2′5′-oligoadenylate synthetase (2′5′AS) is increased in preclinical Type 1 diabetes.

被引:0
|
作者
Bonnevie-Nielsen, V
Ilonen, J
Simell, T
Simell, O
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Univ Turku, SF-20500 Turku, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
313
引用
收藏
页码:A112 / A113
页数:2
相关论文
共 50 条
  • [1] The antiviral 2′,5′-oligoadenylate synthetase is persistently activated in type 1 diabetes
    Bonnevie-Nielsen, V
    Martensen, PM
    Justesen, J
    Kyvik, KO
    Kristensen, B
    Levin, K
    Beck-Nielsen, H
    Worsaa, A
    Dyrberg, T
    CLINICAL IMMUNOLOGY, 2000, 96 (01) : 11 - 18
  • [2] Locus for antiviral enzyme 2′,5′oligoadenylate synthetase (OAS) on chromosome 12q24 influences predisposition to Type 1 diabetes.
    Field, LL
    Bonnevie-Nielsen, V
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A59 - A59
  • [3] Studies on the association between 2'5'-oligoadenylate synthetase and type 1 diabetes
    Zarghami, M
    Bonnevie-Nielsen, V
    Tobias, R
    Engel, M
    Graham, J
    McNeney, B
    Schaefer, J
    Lernmark, A
    Field, L
    TISSUE ANTIGENS, 2002, 59 : 53 - 53
  • [4] CONSTITUTIVE EXPRESSION OF A 2',5'-OLIGOADENYLATE SYNTHETASE CDNA RESULTS IN INCREASED ANTIVIRAL ACTIVITY AND GROWTH SUPPRESSION
    RYSIECKI, G
    GEWERT, DR
    WILLIAMS, BRG
    JOURNAL OF INTERFERON RESEARCH, 1989, 9 (06): : 649 - 657
  • [5] PORCINE CONCEPTUS PROTEINS - ANTIVIRAL ACTIVITY AND EFFECT ON 2',5'-OLIGOADENYLATE SYNTHETASE
    SHORT, EC
    GEISERT, RD
    GROOTHUIS, PG
    BLAIR, RM
    SCHMITT, RAM
    FULTON, RW
    BIOLOGY OF REPRODUCTION, 1992, 46 (03) : 464 - 469
  • [6] RNA regulation of the antiviral protein 2′-5′-oligoadenylate synthetase
    Schwartz, Samantha L.
    Conn, Graeme L.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2019, 10 (04)
  • [7] Activity of constitutive, antiviral enzyme (2′5′-oligoadenylate synthetase) is significantly correlated with GADA levels in T1D families
    Bonnevie-Nielsen, V.
    Lernmark, A.
    Zheng, D. -J.
    Daniels, T.
    Lu, S.
    Bekris, L.
    Field, L.
    DIABETOLOGIA, 2006, 49 : 173 - 173
  • [8] (2'-5') OLIGOADENYLATE AND ITS SYNTHETASE
    SOKAWA, Y
    SEIKAGAKU, 1981, 53 (11): : 1234 - 1238
  • [9] Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene
    Bonnevie-Nielsen, V
    Field, LL
    Lu, S
    Zheng, DJ
    Li, M
    Martensen, PM
    Nielsen, TB
    Beck-Nielsen, H
    Lau, YL
    Pociot, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) : 623 - 633
  • [10] A human cellular noncoding RNA activates the antiviral protein 2′-5′-oligoadenylate synthetase 1
    Calderon, Brenda M.
    Conn, Graeme L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (41) : 16115 - 16124